Ask AI
ProCE Banner Series

Advancing Frontline Strategies in BRAF-Mutant mCRC

This program will explore the expanding role of biomarker-driven therapy in the frontline setting, with particular emphasis on targeted treatment approaches for patients with BRAF V600E–mutant disease. In addition to pivotal trial results, the program will address practical considerations including early and comprehensive molecular testing, interpretation of biomarker results at diagnosis, integration of targeted therapy into first-line treatment planning, and implications for subsequent sequencing.

Key Takeaways

  • Review the role of comprehensive molecular testing at diagnosis in metastatic colorectal cancer
  • Discuss clinical data supporting first-line targeted approaches in BRAF V600E–mutant disease
  • Consider practical strategies for integrating biomarker-driven therapy into frontline treatment planning and subsequent sequencing

All Events

Advancing Frontline Strategies in BRAF-Mutant mCRC

Upcoming Events

April

01

2026

12:15 PM - 12:55 PM Eastern Time (ET)

Virtual